The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

The UNC technology, developed by Pediatrics Professor Chengwen Li, M.D., Ph.D., uses adeno-associated viruses (AAVs) to ferry ...

Randee’s cancer had metastasized. When her doctor tested her for the PIK3CA gene mutation, she was able to make informed ...

Last week, it was announced that Genentech, a founding company in the biotech industry, plans to build a $700 million, ...

First-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib ...

A new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and ...

President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in the United States, it said Wednesday.

More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...

Explore Lineage Cell Therapeutics' Q1 2025 insights, including OpRegen progress, a manufacturing milestone, key clinical data, and a strong financial outlook.

Headlines across North Carolina Monday and Tuesday included 400 new jobs in Holly Springs; flooding risk in the mountains eases; Congressman Chuck Edwards accused for hitting someone with a clipboard ...